HeartSciences Inc. (HSCSW) stock
HSCSWNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCS
$0.07−0.03 (-30.62%)
Close on Oct 30, 2026Market cap $15.89MP/E –Yield 0.00%
HeartSciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
HeartSciences's operating income for the twelve months ending Jul 31, 2026 was -$9.48M. For fiscal 2026 it was -$8.41M. The highest annual figure on record is -$4.71M in fiscal 2022.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | -$8.41M | – |
| FY2025 | Apr 30, 2025 | -$8.35M | – |
| FY2024 | Apr 30, 2024 | -$6.31M | – |
| FY2023 | Apr 30, 2023 | -$6.11M | – |
| FY2022 | Apr 30, 2022 | -$4.71M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027 | Jul 31, 2026 | -$2.94M | – |
| Q4 FY2026 | Apr 30, 2026 | -$2.54M | – |
| Q3 FY2026 | Jan 31, 2026 | -$1.93M | – |
| Q2 FY2026 | Oct 31, 2025 | -$2.07M | – |
| Q1 FY2026 | Jul 31, 2025 | -$1.87M | – |
| Q4 FY2025 | Apr 30, 2025 | -$1.92M | – |
| Q3 FY2025 | Jan 31, 2025 | -$2.37M | – |
| Q2 FY2025 | Oct 31, 2024 | -$1.99M | – |
| Q1 FY2025 | Jul 31, 2024 | -$2.08M | – |
| Q4 FY2024 | Apr 30, 2024 | -$1.88M | – |
| Q3 FY2024 | Jan 31, 2024 | -$1.53M | – |
| Q2 FY2024 | Oct 31, 2023 | -$1.57M | – |
| Q1 FY2024 | Jul 31, 2023 | -$1.33M | – |
| Q4 FY2023 | Apr 30, 2023 | -$1.60M | – |
| Q3 FY2023 | Jan 31, 2023 | -$1.31M | – |
| Q2 FY2023 | Oct 31, 2022 | -$1.77M | – |
| Q1 FY2023 | Jul 31, 2022 | -$1.43M | – |
| Q4 FY2022 | Apr 30, 2022 | -$1.98M | – |
| Q3 FY2022 | Jan 31, 2022 | -$1.10M | – |
| Q2 FY2022 | Oct 31, 2021 | -$956.86K | – |
| Q1 FY2022 | Jul 31, 2021 | -$674.45K | – |